These data further demonstrated that cetuximab downregulated tumor-induced angiogenesis in the 2cKO mouse model of HNSCC by inhibiting the HIF-1α and Notch1 pathways. This evidence concerns the gene HIF1A and head and neck squamous cell carcinoma.